| Literature DB >> 9817190 |
Abstract
The introduction of cyclosporin A has led to improved survival of allografts in humans. However, the use of cyclosporin A is associated with an increased prevalence of hypertension in kidney transplant recipients. Renal vasoconstriction and enhancement of tubular reabsorption contribute to this hypertensive effect. Concomitant treatment with calcium channel blockers blocks or ameliorates most of these adverse effects. This paper reviews the short-term effects of the calcium channel blocker amlodipine on plasma levels of cyclosporin A and its interaction with blood pressure and kidney function.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9817190
Source DB: PubMed Journal: J Hypertens Suppl ISSN: 0952-1178